☆ 4.5 Article

Development, optimization, and scale-up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus-1

BIOTECHNOLOGY JOURNAL (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Current landscape and perspective of oncolytic viruses and their combination therapies

Yinghan Su et al.

Summary: Oncolytic virotherapy has become an important strategy in cancer immunotherapy by reshaping the tumor microenvironment and inducing an antitumor immune response. The combination therapy of oncolytic viruses and immunotherapy has shown promising results in preclinical and clinical studies.

TRANSLATIONAL ONCOLOGY (2022)

Add to Collection

Review Oncology

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy

Masmudur M. Rahman et al.

Summary: Oncolytic viruses (OVs) are a novel cancer treatment modality that selectively target and kill cancer cells while sparing normal ones. Engineered OVs show great potential in clinical trials, but combination therapies with other treatments may further improve their efficacy.

CANCERS (2021)

Add to Collection

Article Immunology

Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures

Julia Puppin Chaves Fulber et al.

Summary: The study successfully transferred NDV production to cell culture, developing methods to replicate NDV in Vero and HEK293 suspension cultures and produce high viral titers. This lays the foundation for a scalable vaccine manufacturing process.

VACCINES (2021)

Add to Collection

Article Oncology

Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation

Kotaro Sugawara et al.

Summary: The study showed that combination therapy of oncolytic virus G47 Delta and immune checkpoint inhibitors can enhance antitumor activity synergistically, with the combination of G47 Delta and anti-CTLA-4 antibody working particularly effectively. The therapy resulted in the recruitment of effector T cells into the tumor and a reduction in regulatory T cells.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Add to Collection

Review Cell Biology

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

Norah Aldrak et al.

Summary: Oncolytic virotherapy, particularly using oHSV, has emerged as a viable therapeutic option for aggressive and resistant cancers. oHSV can target cancer cells and activate the host immunity to attack tumors, leading to direct killing of cancer cells. Different variants of oHSV have been developed to optimize its anti-tumor effects in clinical trials.

CELLS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy

Laura Menotti et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Vero cell upstream bioprocess development for the production of viral vectors and vaccines

Sascha Kiesslich et al.

BIOTECHNOLOGY ADVANCES (2020)

Add to Collection

Article Immunology

Development of suspension adapted Vero cell culture process technology for production of viral vaccines

Chun Fang Shen et al.

VACCINE (2019)

Add to Collection

Article Immunology

Adaptation of Vero cells to suspension growth for rabies virues production in different serum free media

Samia Rourou et al.

VACCINE (2019)

Add to Collection

Review Virology

Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

Valeria Cagno et al.

VIRUSES-BASEL (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor

A. J. Valkama et al.

GENE THERAPY (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

Bioreactor production of recombinant herpes simplex virus vectors

David R. Knop et al.

BIOTECHNOLOGY PROGRESS (2007)

Add to Collection

Article Biotechnology & Applied Microbiology

Development and optimization of an adenovirus production process

A Kamen et al.

JOURNAL OF GENE MEDICINE (2004)

Add to Collection

Article Biotechnology & Applied Microbiology

Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors

JB Wechuck et al.

BIOTECHNOLOGY AND BIOENGINEERING (2002)

Add to Collection

Article Biotechnology & Applied Microbiology

Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors

A Ozuer et al.

BIOTECHNOLOGY PROGRESS (2002)

Add to Collection

Article Biotechnology & Applied Microbiology

Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors

A Ozuer et al.

BIOTECHNOLOGY AND BIOENGINEERING (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.